Abbott issues warning for 155K pain relief devices

Abbott has received reports of 73 injuries concerning its Abbott Proclaim and Infinity neurostimulation systems, which deliver low-intensity electrical impulses and are used for chronic pain, the FDA said Sept. 13. 

Advertisement

The devices are indicated for spinal cord and deep brain stimulation. The product can be controlled through a mobile app, including halting therapy to begin magnetic resonance imaging. Abbott said some patients have reported being unable to exit the MRI mode from the app, which could require surgery to replace the device. 

Customers for about 155,000 Proclaim and Infinity systems have been notified after Abbott recorded 73 injuries and 186 incidents. The company instructed implanting surgeons to advise patients to not delete bluetooth connection between their phone and the device.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.